ENTITY

CEL-SCI (CVM US)

3
Analysis
Health CareUnited States
CEL-SCI Corporation operates as a biotechnology company. The Company engages in the research and development of immunotherapy products for the treatment of cancer, autoimmune, and infectious diseases. CEL-SCI offers its services across North America.
more
bullishCEL-SCI
09 Dec 2024 23:00Issuer-paid

CVM: CRO Selected for Registrational Trial

CEL-SCI is developing two platforms: Multikine and LEAPS. Multikine has completed a Phase 3 trial for head and neck cancer while LEAPS is...

Share
bullishCEL-SCI
29 Aug 2024 05:00Issuer-paid

CVM: Start Your Engines - FDA Green Lights Confirmatory Registration Study

CEL-SCI is developing two platforms: Multikine and LEAPS. Multikine has completed a Phase 3 trial for head and neck cancer while LEAPS is...

Share
bullishCEL-SCI
21 May 2024 22:00Issuer-paid

CVM: Confirmatory Study Clarity

CEL-SCI is developing two platforms: Multikine and LEAPS. Multikine has completed a Phase 3 trial for head and neck cancer while LEAPS is...

Share
No more insights
x